By continuing to use Symptoma®, you confirm you accept the cookies. More on
544301 to 544400 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.
Advances in malignant mesothelioma.
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
Hereditary Autoinflammatory Diseases
Sorafenib in advanced clear-cell renal-cell carcinoma.
M Haseeb Zubair
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
Headache, Periorbital Edema, Weight Gain, peripheral cyanosis
Fibroblasts in cancer.
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
TGFbeta in Cancer.
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
Multi-Ethnic Study of Atherosclerosis: objectives and design.
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Sorafenib in advanced hepatocellular carcinoma.
New functions for the matrix metalloproteinases in cancer progression.
Mild cognitive impairment: clinical characterization and outcome.
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
Prevention of HIV-1 infection with early antiretroviral therapy.
Epithelial-mesenchymal transitions in tumour progression.
MicroRNA signatures in human cancers.
A perivascular niche for brain tumor stem cells.
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.
Malignant astrocytic glioma: genetics, biology, and paths to treatment.
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
The retinoblastoma tumour suppressor in development and cancer.
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.
Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex.
Tumor suppressor genes.
Histone deacetylase activity is required for full transcriptional repression by mSin3A.
The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.
Human retinoblastoma susceptibility gene: cloning, identification, and sequence.
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
Cellular targets for transformation by the adenovirus E1A proteins.
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.
Effects of an Rb mutation in the mouse.
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
Mutation and cancer: statistical study of retinoblastoma.
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
IDH1 and IDH2 mutations in gliomas.
Integrative genomics viewer.
High frequency of mutations of the PIK3CA gene in human cancers.
MGMT gene silencing and benefit from temozolomide in glioblastoma.
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Diarrhea, Tachycardia, blood in stool, acute diarrhea, Headache, acute headache, bilateral
An integrated genomic analysis of human glioblastoma multiforme.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.
Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.
Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors.
Diarrhea, Tachycardia, blood in stool, acute diarrhea, Headache, acute headache
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.
Medulloblastoma comprises four distinct molecular variants.
Metagenes and molecular pattern discovery using matrix factorization.
Medulloblastoma growth inhibition by hedgehog pathway blockade.
The genetic landscape of the childhood cancer medulloblastoma.
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
Identification of a cancer stem cell in human brain tumors.
Altered neural cell fates and medulloblastoma in mouse patched mutants.
Identification of human brain tumour initiating cells.
Histological grading and staging of chronic hepatitis.
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guid...
Unidentified curved bacilli on gastric epithelium in active chronic gastritis.